These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prevention and risk factors of the HBV recurrence after orthotopic liver transplantation: 160 cases follow-up study. Xie SB; Zhu JY; Ying Z; Zeng LJ; Chao M; Lu MQ Transplantation; 2010 Oct; 90(7):786-90. PubMed ID: 20703179 [TBL] [Abstract][Full Text] [Related]
23. European hepatitis B immunoglobulin trials: prevention of recurrent hepatitis B after liver transplantation. Krüger M Clin Transplant; 2000; 14 Suppl 2():14-9. PubMed ID: 10965959 [TBL] [Abstract][Full Text] [Related]
24. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant. Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942 [TBL] [Abstract][Full Text] [Related]
26. Hepatitis B prophylaxis using lamivudine and individualized low-dose hepatitis B immunoglobulin in living donor liver transplantation. Jiang L; Yan L; Wen T; Li B; Zhao J; Yang J; Xu M; Wang W Transplant Proc; 2013; 45(6):2326-30. PubMed ID: 23953544 [TBL] [Abstract][Full Text] [Related]
27. Effects of fialuridine on hepatitis B immune globulin pharmacokinetics following orthotopic liver transplant for chronic hepatitis B viral-induced cirrhosis. McGory RW; Ishitani MB; Oliveira WM; Stevenson WC; Dickson RC; Caldwell SH; Pruett TL Transplant Proc; 1995 Feb; 27(1):1213-4. PubMed ID: 7878854 [No Abstract] [Full Text] [Related]
28. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Samuel D; Bismuth A; Mathieu D; Arulnaden JL; Reynes M; Benhamou JP; Brechot C; Bismuth H Lancet; 1991 Apr; 337(8745):813-5. PubMed ID: 1672913 [TBL] [Abstract][Full Text] [Related]
29. Evolving strategies to prevent HBV recurrence. Roche B; Samuel D Liver Transpl; 2004 Oct; 10(10 Suppl 2):S74-85. PubMed ID: 15382222 [TBL] [Abstract][Full Text] [Related]
30. Prophylaxis of hepatitis B recurrence after liver transplantation with lamivudin and hepatitis B immunoglobulin. Engler S; Sauer P; Klar E; Stremmel W; Kallinowski B Transplant Proc; 2002 Sep; 34(6):2285-7. PubMed ID: 12270401 [No Abstract] [Full Text] [Related]
31. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Markowitz JS; Martin P; Conrad AJ; Markmann JF; Seu P; Yersiz H; Goss JA; Schmidt P; Pakrasi A; Artinian L; Murray NG; Imagawa DK; Holt C; Goldstein LI; Stribling R; Busuttil RW Hepatology; 1998 Aug; 28(2):585-9. PubMed ID: 9696028 [TBL] [Abstract][Full Text] [Related]
32. Discontinuation of Hepatitis B Immunoglobulin by Long-term Hepatitis B Vaccine Inoculation in Preventing Hepatitis B Recurrence After Liver Transplantation. Usui M; Sugimoto K; Kato H; Murata Y; Tanemura A; Kuriyama N; Azumi Y; Kishiwada M; Mizuno S; Sakurai H; Takei Y; Isaji S Transplant Proc; 2016 May; 48(4):1179-83. PubMed ID: 27320582 [TBL] [Abstract][Full Text] [Related]
33. Liver transplantation in European patients with the hepatitis B surface antigen. Samuel D; Muller R; Alexander G; Fassati L; Ducot B; Benhamou JP; Bismuth H N Engl J Med; 1993 Dec; 329(25):1842-7. PubMed ID: 8247035 [TBL] [Abstract][Full Text] [Related]
34. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation. Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765 [TBL] [Abstract][Full Text] [Related]
35. Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. Angus PW; McCaughan GW; Gane EJ; Crawford DH; Harley H Liver Transpl; 2000 Jul; 6(4):429-33. PubMed ID: 10915163 [TBL] [Abstract][Full Text] [Related]
36. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation. Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833 [TBL] [Abstract][Full Text] [Related]
37. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression. Lenci I; Baiocchi L; Tariciotti L; Di Paolo D; Milana M; Santopaolo F; Manzia TM; Toti L; Svicher V; Tisone G; Perno CF; Angelico M Liver Transpl; 2016 Sep; 22(9):1205-13. PubMed ID: 27272189 [TBL] [Abstract][Full Text] [Related]
38. Orthotopic liver transplantation in HBs-antigen positive patients: short-term results. Lee SK; Park YH; Lee WY; Kim SJ; Choi SH; Joh JW; Lee JH; Koh KC; Kim YI; Lee BB Transplant Proc; 1998 Nov; 30(7):3314-5. PubMed ID: 9838465 [No Abstract] [Full Text] [Related]
39. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation. Tillmann HL; Trautwein C; Bock T; Böker KH; Jäckel E; Glowienka M; Oldhafer K; Bruns I; Gauthier J; Condreay LD; Raab HR; Manns MP Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663 [TBL] [Abstract][Full Text] [Related]
40. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends. Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]